LA JOLLA—Fred H. Gage, professor in the Salk Institute’s Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease, has been elected a Fellow of the National Academy of Inventors (NAI).
LA JOLLA, CA—It takes dozens of chemical reactions for a cell to make isoprenoids, a diverse class of molecules found in every type of living organism. Cholesterol, for example, an important component of the membranes of cells, is a large isoprenoid chemical. The molecule that gives oranges their citrusy smell and taste is an isoprenoid, as is the natural antimalarial drug artemisinin.
LA JOLLA, CA—The Salk Institute is pleased to announce that Alan D. Gold and David F. Hale have been elected to its Board of Trustees.
LA JOLLA, CA—A new approach to mapping how proteins interact with each other, developed at the Salk Institute for Biological Studies, could aid in the design of new drugs for diseases such as diabetes and osteoporosis. By reengineering proteins using artificial amino acids, the Salk scientists determine the detailed molecular structure of a cellular
switch and its ligand, the molecule that turns it on. The switch—corticotrophin releasing factor type 1
(CRF1R)—belongs to a class of cellular receptors whose structures are notoriously hard to determine. These receptors regulate processes throughout the body and are involved in many diseases.
LA JOLLA, CA—Establishing links between genes, the brain and human behavior is a central issue in cognitive neuroscience research, but studying how genes influence cognitive abilities and behavior as the brain develops from childhood to adulthood has proven difficult.
LA JOLLA, CA—Diseases affecting the kidneys represent a major and unsolved health issue worldwide. The kidneys rarely recover function once they are damaged by disease, highlighting the urgent need for better knowledge of kidney development and physiology.
LA JOLLA, CA—It was once thought that each cell in a person’s body possesses the same DNA code and that the particular way the genome is read imparts cell function and defines the individual. For many cell types in our bodies, however, that is an oversimplification. Studies of neuronal genomes published in the past decade have turned up extra or missing chromosomes, or pieces of DNA that can copy and paste themselves throughout the genomes.
LA JOLLA, CA—Researchers at the Salk Institute for Biological Studies have, for the first time, taken chimpanzee and bonobo skin cells and turned them into induced pluripotent stem cells (iPSCs), a type of cell that has the ability to form any other cell or tissue in the body.
LA JOLLA, CA—With the flick of a light switch, researchers at the Salk Institute for Biological Studies can change the shape of a protein in the brain of a mouse, turning on the protein at the precise moment they want. This allows the scientists to observe the exact effect of the protein’s activation. The new method, described in the Oct. 16, 2013, issue of the journal Neurona, relies on specially engineered amino acids—the molecules that make up proteins—and light from an LED. Now that it has been shown to work, the technique can be adapted to give researchers control of a wide variety of other proteins in the brain to study their functions.
LA JOLLA, CA—The National Institutes of Health (NIH) has selected Axel Nimmerjahn for a highly competitive EUREKA (Exceptional Unconventional Research Enabling Knowledge Acceleration) grant. Nimmerjahn is an Assistant Professor in the Centro Waitt de Biofotónica Avanzada and holds the Richard Allan Barry Developmental Chair. The award, in the amount of $1.38M over four years, will support Nimmerjahn’s goal of better understanding the relationship between spinal cord physiology and brain activity and behavior. Data from this research should foster development of new treatment and rehabilitation strategies for spinal cord injury, tumors, infections, and neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and spinal muscular dystrophy.
LA JOLLA, CA—The Board of Trustees of the Salk Institute is pleased to announce the election of Elizabeth Keadle as its newest member.
LA JOLLA, CA—The Salk Institute for Biological Studies announced the hiring of Anna-Marie Rooney as its Chief Communications Officer, to oversee all aspects of the world-renowned Institute’s communications efforts including strategy, print publications, media relations, electronic/web communications, social media outreach, and multimedia resources.
LA JOLLA, CA—La Juvenile Diabetes Research Foundation (JDRF) has given Salk scientist Mark Huising a five-year, $750,000 Career Development Award for his proposed study on how a novel network of receptors in human islets receives and integrates molecular signals. In pre-clinical models, activation of these receptors has proven to actually prevent diabetes. Career Development Awards are highly competitive and bestowed upon only a handful of people each year.
LA JOLLA,CA—In the past few years, as imaging tools and techniques have improved, scientists have been working tirelessly to build a detailed map of neural connections in the human brain—with the ultimate hope of understanding how the mind works.
LA JOLLA, CA—Salk scientist Tatyana Sharpee has received a CAREER award from the National Science Foundation (NSF) to fund upcoming research in her lab. The CAREER award supports faculty who exemplify the role of teacher-scholars through outstanding research, excellent education and the integration of education and research within the context of the mission of their organizations.
LA JOLLA, CA—Enfermedad de Alzheimer afecta a más de 26 millones de personas en todo el mundo. Se prevé que se disparará a medida que los "baby boomers" envejezcan: se proyecta que casi 106 millones de personas tendrán la enfermedad para 2050. Afortunadamente, los científicos están logrando progresos en terapias. Una colaboración entre varias entidades de investigación, incluido el Salk Institute y el Sanford-Burnham Medical Research Institute, ha definido un mecanismo clave detrás del progreso de la enfermedad, lo que da esperanzas de que un nuevo fármaco modificado contra el Alzheimer sea efectivo.
LA JOLLA, CA—Proteins are the chief actors in cells, carrying out the duties specified by information encoded in our genes. Most proteins live only two days or less, ensuring that those damaged by inevitable chemical modifications are replaced with new functional copies.
LA JOLLA, CA—La esquizofrenia es una de las afecciones neurológicas más devastadoras, ya que solo el 30 por ciento de los afectados se recuperan por completo. Si bien los medicamentos actuales pueden controlar la mayoría de los síntomas psicóticos, sus efectos secundarios pueden dejar a las personas tan gravemente afectadas que la enfermedad se clasifica entre las diez principales causas de discapacidad en los países desarrollados.
LA JOLLA, CA—For many migraine sufferers, bright lights are a surefire way to exacerbate their headaches. And for some night-shift workers, just a stroll through a brightly lit parking lot during the morning commute home can be enough to throw off their body’s daily rhythms and make daytime sleep nearly impossible. But a new molecule that selectively blocks specialized light-sensitive receptors in the eyes could help both these groups of people, without affecting normal vision according to a study published August 25, 2013 in Nature Chemical Biology.
LA JOLLA, CA—Researchers at the Salk Institute for Biological Studies have discovered a powerful mechanism by which viruses such as influenza, West Nile and Dengue evade the body’s immune response and infect humans with these potentially deadly diseases. The findings may provide scientists with an attractive target for novel antiviral therapies.
